Subscribe

Neal Shore, MD, FACS

Carolina Urologic Research Center
Myrtle Beach, SC

Authored Items

Use of PYLARIFY® in Specific Patient Groups
By Neal Shore, MD, FACS
Web Exclusives
Interview with the Innovators
Dr Neal Shore highlights example patient populations that may benefit from improved staging through the use of PYLARIFY® (piflufolastat F 18), a prostate-specific membrane antigen (PSMA)-targeted PET/CT agent. Read More ›
PYLARIFY and Next-Generation Imaging
By Neal Shore, MD, FACS
Videos
Interview with the Innovators
Dr Neal Shore elaborates on the ability of PYLARIFY® (piflufolastat F 18) to detect metastases and the practical aspects of next-generation imaging. Read More ›
PSMA-Targeted Imaging for Prostate Cancer Treatment
By Neal Shore, MD, FACS
Videos
Interview with the Innovators
Dr Neal Shore discusses the rationale of prostate-specific membrane antigen (PSMA) PET/CT to guide prostate cancer treatment. Read More ›
Overview of Current Imaging Modalities in Prostate Cancer
By Neal Shore, MD, FACS
Videos
Interview with the Innovators
Dr Neal Shore introduces the current global landscape of various imaging modalities for prostate cancer, including a new prostate-specific membrane antigen (PSMA)-targeted PET/CT agent, PYLARIFY® (piflufolastat F 18). Read More ›
CONNECT
Subscribe

Subscribe to
Oncology Practice Management

Stay up to date with oncology news & updates by subscribing to receive the free OPM print publications or weekly e‑Newsletter.

I'd like to receive:

Sign Up for Oncology News

Subscribe to recieve the free, monthly OPM print publication and OPM weekly e‑newsletter.

Subscribe
©2021. Engage Healthcare Communications, LLC. All Rights Reserved. Privacy Policy.